What is internal buy-in?
Internal buy-in is the process of securing alignment across departments such as medical affairs, commercial, R&D, and market access for a particular project, product, or initiative. It involves communicating strategic rationale, addressing concerns, and building consensus to ensure unified execution.
Why is internal buy-in important in pharma?
Without internal alignment, strategies may face delays, inefficiencies, or inconsistent messaging. Strong buy-in leads to faster decision-making, more coordinated implementation, and better outcomes. It is particularly important for high-impact activities such as launch planning, value messaging, or evidence investment.
